Cadavid Diego 4
4 · Fulcrum Therapeutics, Inc. · Filed Jun 26, 2020
Insider Transaction Report
Form 4
Cadavid Diego
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2020-06-25$4.83/sh+1,459$7,047→ 68,244 total - Sale
Common Stock
2020-06-25$22.00/sh−1,459$32,098→ 66,785 total - Exercise/Conversion
Stock Option (right to buy)
2020-06-25−1,459→ 12,277 totalExercise: $4.83Exp: 2028-07-10→ Common Stock (1,459 underlying)
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2019.
- [F2]The shares underlying the option are scheduled to vest in equal quarterly installments from July 16, 2018 through July 15, 2022.